When some 30,000 oncology practitioners, researchers, and patient advocates gather each year for the annual meeting of the American Society of Clinical Oncology (ASCO), we've come to count on some pretty important research updates emerging from that gathering. This year's meeting-ASCO's 51st-proved no exception.
The diagnosis of peritoneal carcinomatosisis can be devastating, but a combination of cytoreductive surgical resection and hyperthermic intraperitoneal chemotherapy has the potential to provide some patients with long-term survival.
While controversial, advances in understanding how prostate cancer treatments impact the physiology of erections have led to increased interest in penile rehabilitation interventions for these patients.
Chemotherapy-induced cardiotoxicity is defined as a poisonous or detrimental effect upon the heart that can delay cancer treatment, decrease survival, and increase morbidity.
The abundance of new genetic tests, while beneficial in many ways, also has limitations.
Potential benefits of wearable technology include reducing obesity, improving sleep quality, prompt detection of health issues, and ongoing monitoring of vital signs or medication adherence.
An oncology nurse navigator learns just how essential the role is, when her own husband is diagnosed with melanoma and a colleague provided just the right support.
